RNA Modification of N6-Methyladenosine Predicts Immune Phenotypes and Therapeutic Opportunities in Kidney Renal Clear Cell Carcinoma

by Huihuang Li, Jiao Hu, Anze Yu, Anze Yu, Belaydi Othmane, Tao Guo, Jinhui Liu, Chunliang Cheng, Jinbo Chen, Xiongbing Zu
Published 2021-03-01

Clinicopathological and prognostic significance of nestin expression in patients with breast cancer: a systematic review and meta-analysis

by Xinyi Zhang, Changsheng Xing, Wenting Guan, Lang Chen, Kai Guo, Anze Yu, Kai Xie
Published 2020-05-01

N6-Methyladenosine in Cancer Immunotherapy: An Undervalued Therapeutic Target

by Chao Quan, Othmane Belaydi, Jiao Hu, Huihuang Li, Anze Yu, Anze Yu, Peihua Liu, Zhenglin Yi, Dongxu Qiu, Wenbiao Ren, Hongzhi Ma, Guanghui Gong, Zhenyu Ou, Minfeng Chen, Yin Sun, Jinbo Chen, Xiongbing Zu
Published 2021-08-01

YTHDF1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy

by Jian Hu, Dongxu Qiu, Anze Yu, Jiao Hu, Hao Deng, Huihuang Li, Zhenglin Yi, Jinbo Chen, Xiongbing Zu
Published 2021-05-01

A Comprehensive Analysis Identified the Key Differentially Expressed Circular Ribonucleic Acids and Methylation-Related Function in Pheochromocytomas and Paragangliomas

by Anze Yu, Anze Yu, Minghao Li, Minghao Li, Changsheng Xing, Danlei Chen, Danlei Chen, Cikui Wang, Cikui Wang, Qiao Xiao, Qiao Xiao, Liang Zhang, Liang Zhang, Yingxian Pang, Yingxian Pang, Yong Wang, Yong Wang, Xiongbing Zu, Xiongbing Zu, Longfei Liu, Longfei Liu
Published 2020-02-01

Clinical Syndromes and Genetic Screening Strategies of Pheochromocytoma and Paraganglioma

by Peihua Liu, Minghao Li, Xiao Guan, Anze Yu, Qiao Xiao, Cikui Wang, Yixi Hu, Feizhou Zhu, Hongling Yin, Xiaoping Yi, Longfei Liu
Published 2018-12-01